Sumitomo Chemical recorded a reversal of equity method investment loss in the fourth quarter of fiscal year 2026. There was no impact on consolidated results, and the content reflects the figures in the individual financial statements.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4005","jir_company_name":"Sumitomo Chemical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-05-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4005-20260514-03.pdf","jir_short_summary":"Sumitomo Chemical recorded a reversal of equity method investment loss in the fourth quarter of fiscal year 2026. There was no impact on consolidated results, and the content reflects the figures in the individual financial statements.","jir_summary":"### Financial Performance Overview\nSumitomo Chemical announced that it reversed a valuation loss on equity method investments in the fourth quarter of fiscal year 2026. The target was Type A common shares of Rabigh Refining & Petrochemical Company, an equity-method affiliate, with a total valuation loss of \u25b313,361 million yen. This was due to a recovery in the fair value of the shares and does not affect the consolidated financial results.\n\n### Impact on Shareholders and Future Outlook\nThe reversal of valuation loss is only reflected in the individual financial statements and has no effect on the consolidated results, thus the direct impact on shareholders and investors is limited. The company also states it will continue to monitor fluctuations in the valuation of affiliated companies\u2019 shares and manage assets appropriately.","jir_financial_highlights":"Reversal amount of equity method investment loss: \u25b313,361 million yen (Reversal of valuation loss recognized in the third quarter of fiscal year 2026)","jir_category":"","jir_hashtags":"#SumitomoChemical, #FinancialResults, #JapanStocks","jir_key_figures":"Reversal amount of equity method investment loss: \u25b313,361 million yen\nValuation loss recognized in the third quarter of fiscal year 2026: 13,361 million yen\nTotal valuation loss amount: Unknown","jir_meta_title":"\u3010Sumitomo Chemical\u3011Reversal of Equity Method Investment Loss\uff5cMay 2026","jir_meta_description":"Sumitomo Chemical recorded a reversal of equity method investment loss in the fourth quarter of fiscal year 2026. There was no impact on consolidated results, and the figures are reflected in the individual financial statements.","jir_og_title":"\u3010Sumitomo Chemical\u3011Reversal of Equity Method Investment Loss\uff5cMay 2026","jir_og_description":"Sumitomo Chemical recorded a reversal of equity method investment loss in the fourth quarter of fiscal year 2026. It does not affect consolidated results.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7702,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-49887","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n